Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Free Subscription

Articles published in Biochem Pharmacol

Retrieve available abstracts of 9 articles:
HTML format
Text format

Single Articles

    February 2019
  1. LIAO HC, Chou YJ, Lin CC, Liu SH, et al
    Andrographolide and its potent derivative exhibit anticancer effects against imatinib-resistant chronic myeloid leukemia cells by downregulating the Bcr-Abl oncoprotein.
    Biochem Pharmacol. 2019 Feb 26. pii: S0006-2952(19)30066.
    PubMed     Text format     Abstract available

    November 2018
  2. WANG LJ, Lee YC, Huang CH, Shi YJ, et al
    Non-mitotic effect of albendazole triggers apoptosis of human leukemia cells via SIRT3/ROS/p38 MAPK/TTP axis-mediated TNF-alpha upregulation.
    Biochem Pharmacol. 2018 Nov 7. pii: S0006-2952(18)30472.
    PubMed     Text format     Abstract available

    August 2018
  3. BERMEJO M, Ambrosioni J, Bautista G, Climent N, et al
    Evaluation of resistance to HIV-1 infection ex vivo of PBMCs isolated from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors.
    Biochem Pharmacol. 2018 Aug 21. pii: S0006-2952(18)30357.
    PubMed     Text format     Abstract available

    July 2018
  4. MARIOTTO E, Bortolozzi R, Volpin I, Carta D, et al
    EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells.
    Biochem Pharmacol. 2018;155:213-223.
    PubMed     Text format     Abstract available

    February 2018
  5. BORTOLOZZI R, Mattiuzzo E, Trentin L, Accordi B, et al
    Ribociclib, A Cdk4/Cdk6 Kinase Inhibitor, Enhances Glucocorticoid Sensitivity In B-Acute Lymphoblastic Leukemia (B-All).
    Biochem Pharmacol. 2018 Feb 3. pii: S0006-2952(18)30056.
    PubMed     Text format     Abstract available

  6. SU Y, Li X, Ma J, Zhao J, et al
    Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo.
    Biochem Pharmacol. 2018;148:13-26.
    PubMed     Text format     Abstract available

    October 2017
  7. HAMDOUN S, Fleischer E, Klinger A, Efferth T, et al
    Lawsone derivatives target the Wnt/beta-catenin signaling pathway in multidrug-resistant acute lymphoblastic leukemia cells.
    Biochem Pharmacol. 2017 Oct 20. pii: S0006-2952(17)30638.
    PubMed     Text format     Abstract available

    September 2017
  8. STEINHILBER D, Marschalek R
    How to effectively treat acute leukemia patients bearing MLL-rearrangements ?
    Biochem Pharmacol. 2017 Sep 21. pii: S0006-2952(17)30603.
    PubMed     Text format     Abstract available

    June 2017
  9. PROBST L, Dachert J, Schenk B, Fulda S, et al
    Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death.
    Biochem Pharmacol. 2017 Jun 5. pii: S0006-2952(17)30435.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.